Tpg Gp A »

Travere Therapeutics shares owned by Tpg Gp A

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Tpg Gp A from 13F filings

Historical chart of Tpg Gp A investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Tpg Gp A consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Tpg Gp A

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 1.0M 1.18

More positions owned by Tpg Gp A

Lifestance Health Group (LFST)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Jackson Financial Com Cl A (JXN)
Life Time Group Holdings Common Stock (LTH)
Sionna Therapeutics (SION)
Beta Technologies Com Shs Cl A (BETA)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Invitation Homes (INVH)
Ngl Energy Partners Com Unit Repst (NGL)
Bicara Therapeutics (BCAX)
Bruker Corp 6.375 Pref Ser A (BRKRP)
Ceribell (CBLL)
Bofa Fin MTNF 0.600% 5/2
Odyssey Therapeutics Common Stock
Achieve Life Sciences (ACHV)

View all positions for Tpg Gp A

Top funds holding Travere Therapeutics

Ing Investment Management
BlackRock
Context Capital Management
Calamos Advisors
Polar Securities
Tenor Capital Management
Wellesley Investment Advisors
Lord, Abbett & Co
Lazard Asset Management
Steelhead Partners
M&G
Citadel Advisors
Ameriprise Financial
DeepCurrents Investment Group
D. E. Shaw & Co

View all funds holding Travere Therapeutics